Stefan Hippenstiel Selected Research

Kruppel-Like Factor 4

1/2021	Krueppel-Like Factor 4 Expression in Phagocytes Regulates Early Inflammatory Response and Disease Severity in Pneumococcal Pneumonia.
2/2013	TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefan Hippenstiel Research Topics

Disease

29	Infections 12/2021 - 06/2004
13	Pneumonia (Pneumonitis) 01/2021 - 07/2006
12	COVID-19 07/2022 - 01/2020
10	Pneumococcal Pneumonia 01/2021 - 06/2006
9	Inflammation (Inflammations) 01/2020 - 11/2007
8	Pneumococcal Infections 01/2021 - 08/2004
7	Sepsis (Septicemia) 01/2018 - 05/2005
5	Chronic Obstructive Pulmonary Disease (COPD) 01/2020 - 03/2006
3	Human Influenza (Influenza) 12/2022 - 01/2019
3	Disease Progression 10/2021 - 08/2020
3	Autolysis 01/2020 - 06/2015
3	Bacterial Pneumonia 01/2018 - 01/2017
3	Acute Lung Injury 01/2018 - 07/2006
3	Emphysema 01/2016 - 01/2015
3	Ventilator-Induced Lung Injury 08/2011 - 01/2010
3	Edema (Dropsy) 07/2006 - 02/2003
2	Critical Illness (Critically Ill) 01/2022 - 07/2009
2	Weight Loss (Weight Reduction) 11/2020 - 08/2020
2	Influenza in Birds (Avian Flu) 07/2018 - 12/2012
2	Pulmonary Hypertension 01/2015 - 07/2006
2	Multiple Organ Failure (MODS) 04/2014 - 08/2011
2	Lung Injury 04/2014 - 01/2010
2	Body Weight (Weight, Body) 09/2013 - 02/2009
2	Respiratory Insufficiency (Respiratory Failure) 12/2010 - 01/2010
2	Atherosclerosis 03/2010 - 03/2009
2	Legionnaires' Disease (Legionnaire's Disease) 12/2008 - 05/2008
2	Septic Shock (Toxic Shock Syndrome) 11/2007 - 04/2007
2	Melanoma (Melanoma, Malignant) 04/2007 - 11/2006
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Hypothermia 12/2021
1	Acute malaria 04/2021
1	Malaria 04/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Bites and Stings (Sting) 10/2018

Drug/Important Bio-Agent (IBA)

15	CytokinesIBA 12/2021 - 05/2005
6	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2020
6	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2004
6	AdrenomedullinIBA 04/2014 - 12/2005
4	Streptococcus pneumoniae plY proteinIBA 01/2021 - 07/2006
4	Antiviral Agents (Antivirals)IBA 01/2019 - 06/2004
4	Interleukin-8 (Interleukin 8)IBA 12/2008 - 12/2004
4	p38 Mitogen-Activated Protein KinasesIBA 11/2008 - 02/2003
3	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2020
3	Peptides (Polypeptides)IBA 10/2021 - 04/2007
3	DNA (Deoxyribonucleic Acid)IBA 10/2018 - 07/2006
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2017 - 12/2004
3	Virulence Factors (Pathogenicity Factors)IBA 07/2009 - 08/2005
2	Complement System Proteins (Complement)IBA 01/2022 - 01/2020
2	Messenger RNA (mRNA)IBA 10/2021 - 08/2004
2	AntibodiesIBA 10/2021 - 11/2013
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2016
2	Biological ProductsIBA 04/2021 - 07/2018
2	ProteomeIBA 01/2021 - 01/2020
2	Kruppel-Like Factor 4IBA 01/2021 - 02/2013
2	InterleukinsIBA 01/2021 - 02/2013
2	EnzymesIBA 01/2021 - 05/2008
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2010
2	CV07-209IBA 11/2020 - 08/2020
2	Monoclonal AntibodiesIBA 11/2020 - 08/2020
2	EpitopesIBA 11/2020 - 08/2020
2	Neutralizing AntibodiesIBA 11/2020 - 08/2020
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 05/2005
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 04/2008
2	N-Acetylmuramoyl-L-alanine Amidase (Autolysin)IBA 01/2020 - 10/2015
2	Phosphates (Orthophosphate)IBA 01/2018 - 08/2011
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2015 - 11/2008
2	AlbuminsIBA 11/2013 - 05/2005
2	endolysinIBA 09/2013 - 02/2009
2	Small Interfering RNA (siRNA)IBA 02/2013 - 12/2008
2	ChromatinIBA 02/2013 - 07/2006
2	Interleukin-15 (Interleukin 15)IBA 07/2008 - 05/2007
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2007 - 11/2006
1	N 30IBA 07/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2022
1	Plasminogen Activators (Plasminogen Activator)IBA 01/2022
1	Chemotactic FactorsIBA 01/2022
1	Factor XII (Hageman Factor)IBA 01/2022
1	FibrinIBA 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	KaolinIBA 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA 01/2022
1	BNT162 VaccineIBA 10/2021
1	HLA-C Antigens (HLA-C)IBA 10/2021
1	Proteasome Endopeptidase Complex (Proteasome)IBA 04/2021
1	CalciumIBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 11/2020
1	InterferonsIBA 01/2020
1	GelatinIBA 10/2018
1	AlginatesIBA 10/2018
1	DNA receptor (receptor, DNA)IBA 10/2018
1	SphingosineIBA 01/2018
1	sphingosine kinaseIBA 01/2018

Therapy/Procedure

9	Therapeutics 07/2022 - 07/2006
5	Artificial Respiration (Mechanical Ventilation) 08/2021 - 01/2010
2	Pneumonectomy (Lung Volume Reduction) 01/2016 - 01/2015
2	Mechanical Ventilators (Ventilator) 08/2011 - 12/2010
1	Phage Therapy 12/2021
1	Length of Stay 01/2018